nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—Interferon gamma signaling—CIITA—multiple sclerosis	0.0166	0.0225	CbGpPWpGaD
Tiludronate—PTPN1—Regulation of IFNA signaling—IFNB1—multiple sclerosis	0.0164	0.0222	CbGpPWpGaD
Tiludronate—ATP6V1A—brainstem—multiple sclerosis	0.016	0.11	CbGeAlD
Tiludronate—ATP6V1A—retina—multiple sclerosis	0.0155	0.107	CbGeAlD
Tiludronate—PTPN1—nervous system—multiple sclerosis	0.014	0.0966	CbGeAlD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.014	0.019	CbGpPWpGaD
Tiludronate—PTPN1—central nervous system—multiple sclerosis	0.0135	0.093	CbGeAlD
Tiludronate—PTPN1—cerebellum—multiple sclerosis	0.0132	0.0909	CbGeAlD
Tiludronate—PTPN1—N-cadherin signaling events—CNR1—multiple sclerosis	0.0126	0.0171	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—MX1—multiple sclerosis	0.0124	0.0168	CbGpPWpGaD
Tiludronate—PTPN1—Regulation of IFNG signaling—IFNG—multiple sclerosis	0.0122	0.0165	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-DRA—multiple sclerosis	0.0115	0.0155	CbGpPWpGaD
Tiludronate—ATP6V1A—medulla oblongata—multiple sclerosis	0.0112	0.077	CbGeAlD
Tiludronate—PTPN1—Interferon alpha/beta signaling—IRF5—multiple sclerosis	0.0108	0.0146	CbGpPWpGaD
Tiludronate—PTPN1—brain—multiple sclerosis	0.0107	0.0738	CbGeAlD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—S1PR1—multiple sclerosis	0.0106	0.0144	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—IRF8—multiple sclerosis	0.0103	0.014	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—HLA-G—multiple sclerosis	0.0103	0.014	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—IRF5—multiple sclerosis	0.0103	0.0139	CbGpPWpGaD
Tiludronate—ATP6V1A—midbrain—multiple sclerosis	0.0102	0.0704	CbGeAlD
Tiludronate—ATP6V1A—spinal cord—multiple sclerosis	0.00996	0.0687	CbGeAlD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-G—multiple sclerosis	0.00983	0.0133	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—IRF8—multiple sclerosis	0.00983	0.0133	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.00964	0.013	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-DRB4—multiple sclerosis	0.00861	0.0116	CbGpPWpGaD
Tiludronate—ATP6V1A—nervous system—multiple sclerosis	0.00839	0.0579	CbGeAlD
Tiludronate—PTPN1—Interferon Signaling—CIITA—multiple sclerosis	0.00813	0.011	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—multiple sclerosis	0.00811	0.011	CbGpPWpGaD
Tiludronate—ATP6V1A—central nervous system—multiple sclerosis	0.00808	0.0557	CbGeAlD
Tiludronate—PTPN1—Regulation of IFNA signaling—TYK2—multiple sclerosis	0.00794	0.0107	CbGpPWpGaD
Tiludronate—ATP6V1A—cerebellum—multiple sclerosis	0.0079	0.0545	CbGeAlD
Tiludronate—PTPN1—Interferon alpha/beta signaling—IFNB1—multiple sclerosis	0.00787	0.0106	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-DPB1—multiple sclerosis	0.00786	0.0106	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.00749	0.0101	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.00729	0.00987	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—CBLB—multiple sclerosis	0.00682	0.00922	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.00668	0.00904	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—VCAM1—multiple sclerosis	0.00657	0.0089	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-DQA1—multiple sclerosis	0.00656	0.00887	CbGpPWpGaD
Tiludronate—ATP6V1A—brain—multiple sclerosis	0.00642	0.0442	CbGeAlD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-DQB1—multiple sclerosis	0.00613	0.0083	CbGpPWpGaD
Tiludronate—PTPN1—Growth hormone receptor signaling—STAT3—multiple sclerosis	0.00593	0.00802	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00585	0.00791	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—MX1—multiple sclerosis	0.00579	0.00784	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—HLA-B—multiple sclerosis	0.00578	0.00782	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DRB4—multiple sclerosis	0.00575	0.00778	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-DRA—multiple sclerosis	0.0056	0.00759	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-B—multiple sclerosis	0.00551	0.00746	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—CIITA—multiple sclerosis	0.00543	0.00735	CbGpPWpGaD
Tiludronate—PTPN1—Growth hormone receptor signaling—MAPK1—multiple sclerosis	0.00539	0.00729	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—HLA-A—multiple sclerosis	0.00535	0.00725	CbGpPWpGaD
Tiludronate—Bone pain—Cladribine—multiple sclerosis	0.0053	0.0456	CcSEcCtD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-A—multiple sclerosis	0.0051	0.00691	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL7—multiple sclerosis	0.00505	0.00683	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IRF5—multiple sclerosis	0.00502	0.0068	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SELPLG—multiple sclerosis	0.00488	0.0066	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CD58—multiple sclerosis	0.00488	0.0066	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MERTK—multiple sclerosis	0.00488	0.0066	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-G—multiple sclerosis	0.0048	0.0065	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IRF8—multiple sclerosis	0.0048	0.0065	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL7R—multiple sclerosis	0.00474	0.00642	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—HLA-DRB1—multiple sclerosis	0.00466	0.00631	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—TYK2—multiple sclerosis	0.00456	0.00617	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—ICAM1—multiple sclerosis	0.00448	0.00606	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.00441	0.00596	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—STAT3—multiple sclerosis	0.00394	0.00533	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.00392	0.0053	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MX1—multiple sclerosis	0.00387	0.00523	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-DPB1—multiple sclerosis	0.00384	0.00519	CbGpPWpGaD
Tiludronate—PTPN1—Interferon alpha/beta signaling—TYK2—multiple sclerosis	0.00382	0.00516	CbGpPWpGaD
Tiludronate—Back pain—Fingolimod—multiple sclerosis	0.00378	0.0326	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DRA—multiple sclerosis	0.00374	0.00506	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IFNB1—multiple sclerosis	0.00366	0.00496	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NOD1—multiple sclerosis	0.00353	0.00478	CbGpPWpGaD
Tiludronate—Bone pain—Mitoxantrone—multiple sclerosis	0.00348	0.03	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00344	0.00466	CbGpPWpGaD
Tiludronate—PTPN1—Interferon gamma signaling—IFNG—multiple sclerosis	0.00341	0.00461	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IRF5—multiple sclerosis	0.00335	0.00454	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—VCAM1—multiple sclerosis	0.00321	0.00435	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IRF8—multiple sclerosis	0.0032	0.00434	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-G—multiple sclerosis	0.0032	0.00434	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-DQA1—multiple sclerosis	0.0032	0.00433	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—STAT3—multiple sclerosis	0.00319	0.00432	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLEK—multiple sclerosis	0.00301	0.00408	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-DQB1—multiple sclerosis	0.003	0.00405	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.00285	0.00386	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—IL1B—multiple sclerosis	0.00284	0.00385	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-B—multiple sclerosis	0.00269	0.00364	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00261	0.00353	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DPB1—multiple sclerosis	0.00256	0.00347	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—HLA-A—multiple sclerosis	0.00249	0.00337	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IFNB1—multiple sclerosis	0.00245	0.00331	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—TYK2—multiple sclerosis	0.0024	0.00325	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—STAT3—multiple sclerosis	0.00238	0.00322	CbGpPWpGaD
Tiludronate—Asthenia—Fingolimod—multiple sclerosis	0.00229	0.0197	CcSEcCtD
Tiludronate—PTPN1—Interferon Signaling—HLA-DRB1—multiple sclerosis	0.00228	0.00308	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—ICAM1—multiple sclerosis	0.00219	0.00296	CbGpPWpGaD
Tiludronate—Diarrhoea—Fingolimod—multiple sclerosis	0.00218	0.0188	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—MAPK1—multiple sclerosis	0.00217	0.00293	CbGpPWpGaD
Tiludronate—Back pain—Cladribine—multiple sclerosis	0.00215	0.0185	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—VCAM1—multiple sclerosis	0.00214	0.0029	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DQA1—multiple sclerosis	0.00214	0.00289	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SELE—multiple sclerosis	0.00212	0.00287	CbGpPWpGaD
Tiludronate—Dizziness—Fingolimod—multiple sclerosis	0.00211	0.0182	CcSEcCtD
Tiludronate—PTPN1—Immune System—P2RX7—multiple sclerosis	0.00208	0.00282	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00206	0.00279	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MAPK1—multiple sclerosis	0.00206	0.00278	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00203	0.00275	CbGpPWpGaD
Tiludronate—Headache—Fingolimod—multiple sclerosis	0.002	0.0172	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DQB1—multiple sclerosis	0.002	0.00271	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD226—multiple sclerosis	0.00194	0.00262	CbGpPWpGaD
Tiludronate—Myalgia—Cladribine—multiple sclerosis	0.00189	0.0163	CcSEcCtD
Tiludronate—Arthralgia—Cladribine—multiple sclerosis	0.00189	0.0163	CcSEcCtD
Tiludronate—PTPN1—Immune System—HLA-DRB4—multiple sclerosis	0.00188	0.00254	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00182	0.00247	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-B—multiple sclerosis	0.0018	0.00243	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—TYK2—multiple sclerosis	0.00178	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CIITA—multiple sclerosis	0.00177	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL2RA—multiple sclerosis	0.00168	0.00228	CbGpPWpGaD
Tiludronate—Rhinitis—Mitoxantrone—multiple sclerosis	0.00168	0.0145	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-A—multiple sclerosis	0.00166	0.00225	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IFNG—multiple sclerosis	0.00166	0.00225	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00165	0.0142	CcSEcCtD
Tiludronate—PTPN1—Immune System—C4A—multiple sclerosis	0.00165	0.00223	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL7—multiple sclerosis	0.00165	0.00223	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GPC5—multiple sclerosis	0.00164	0.00222	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—STAT3—multiple sclerosis	0.00158	0.00214	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PDCD1—multiple sclerosis	0.00158	0.00214	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LINGO1—multiple sclerosis	0.00155	0.0021	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LINGO1—multiple sclerosis	0.00155	0.0021	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL7R—multiple sclerosis	0.00155	0.0021	CbGpPWpGaD
Tiludronate—Pain—Cladribine—multiple sclerosis	0.00155	0.0133	CcSEcCtD
Tiludronate—Arthralgia—Azathioprine—multiple sclerosis	0.00154	0.0132	CcSEcCtD
Tiludronate—Myalgia—Azathioprine—multiple sclerosis	0.00154	0.0132	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—ITGA4—multiple sclerosis	0.00153	0.00208	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—MAPK1—multiple sclerosis	0.00153	0.00207	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IFNB1—multiple sclerosis	0.00152	0.00206	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HLA-DRB1—multiple sclerosis	0.00152	0.00206	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00148	0.0128	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—multiple sclerosis	0.00147	0.00199	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00147	0.00199	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—ICAM1—multiple sclerosis	0.00146	0.00198	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	0.00144	0.00195	CbGpPWpGaD
Tiludronate—Abdominal pain—Cladribine—multiple sclerosis	0.00143	0.0123	CcSEcCtD
Tiludronate—PTPN1—Immune System—CBLB—multiple sclerosis	0.00142	0.00193	CbGpPWpGaD
Tiludronate—Back pain—Mitoxantrone—multiple sclerosis	0.00141	0.0121	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—TAGAP—multiple sclerosis	0.00135	0.00182	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TAGAP—multiple sclerosis	0.00135	0.00182	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00134	0.0116	CcSEcCtD
Tiludronate—Asthenia—Cladribine—multiple sclerosis	0.0013	0.0112	CcSEcCtD
Tiludronate—Rhinitis—Triamcinolone—multiple sclerosis	0.00127	0.0109	CcSEcCtD
Tiludronate—Rhinitis—Methylprednisolone—multiple sclerosis	0.00126	0.0109	CcSEcCtD
Tiludronate—PTPN1—Immune System—MX1—multiple sclerosis	0.00126	0.00171	CbGpPWpGaD
Tiludronate—Myalgia—Mitoxantrone—multiple sclerosis	0.00124	0.0107	CcSEcCtD
Tiludronate—Arthralgia—Mitoxantrone—multiple sclerosis	0.00124	0.0107	CcSEcCtD
Tiludronate—Diarrhoea—Cladribine—multiple sclerosis	0.00124	0.0107	CcSEcCtD
Tiludronate—PTPN1—Immune System—HLA-DRA—multiple sclerosis	0.00122	0.00165	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.0012	0.0104	CcSEcCtD
Tiludronate—Dizziness—Cladribine—multiple sclerosis	0.0012	0.0103	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00119	0.00161	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—TYK2—multiple sclerosis	0.00119	0.00161	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK1—multiple sclerosis	0.00118	0.0016	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—S1PR1—multiple sclerosis	0.00118	0.00159	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—S1PR1—multiple sclerosis	0.00118	0.00159	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—multiple sclerosis	0.00117	0.00159	CbGpPWpGaD
Tiludronate—Abdominal pain—Azathioprine—multiple sclerosis	0.00116	0.01	CcSEcCtD
Tiludronate—PTPN1—Immune System—NOD1—multiple sclerosis	0.00115	0.00156	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GPC5—multiple sclerosis	0.00115	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GPC5—multiple sclerosis	0.00115	0.00155	CbGpPWpGaD
Tiludronate—Headache—Cladribine—multiple sclerosis	0.00113	0.00977	CcSEcCtD
Tiludronate—PTPN1—Immune System—MALT1—multiple sclerosis	0.00111	0.00151	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	0.00111	0.0015	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRF5—multiple sclerosis	0.0011	0.00148	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00108	0.00934	CcSEcCtD
Tiludronate—Nausea—Cladribine—multiple sclerosis	0.00108	0.00926	CcSEcCtD
Tiludronate—Vertigo—Prednisolone—multiple sclerosis	0.00107	0.00926	CcSEcCtD
Tiludronate—ATP6V1A—Disease—RPL5—multiple sclerosis	0.00106	0.00144	CbGpPWpGaD
Tiludronate—Back pain—Triamcinolone—multiple sclerosis	0.00106	0.00916	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—IL2RA—multiple sclerosis	0.00105	0.00142	CbGpPWpGaD
Tiludronate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00105	0.00902	CcSEcCtD
Tiludronate—PTPN1—Immune System—IRF8—multiple sclerosis	0.00105	0.00142	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFIH1—multiple sclerosis	0.00105	0.00142	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-G—multiple sclerosis	0.00105	0.00142	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SLC11A1—multiple sclerosis	0.00102	0.00138	CbGpPWpGaD
Tiludronate—Pain—Mitoxantrone—multiple sclerosis	0.00102	0.00876	CcSEcCtD
Tiludronate—Diarrhoea—Azathioprine—multiple sclerosis	0.00101	0.00867	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—RGS1—multiple sclerosis	0.001	0.00136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RGS1—multiple sclerosis	0.001	0.00136	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	0.000991	0.00134	CbGpPWpGaD
Tiludronate—Vertigo—Triamcinolone—multiple sclerosis	0.000988	0.00851	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL2—multiple sclerosis	0.000987	0.00134	CbGpPWpGaD
Tiludronate—Vertigo—Methylprednisolone—multiple sclerosis	0.000986	0.00849	CcSEcCtD
Tiludronate—PTPN1—Immune System—TNFAIP3—multiple sclerosis	0.00098	0.00133	CbGpPWpGaD
Tiludronate—Dizziness—Azathioprine—multiple sclerosis	0.000973	0.00838	CcSEcCtD
Tiludronate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000973	0.00838	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—GPR65—multiple sclerosis	0.00095	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GPR65—multiple sclerosis	0.00095	0.00129	CbGpPWpGaD
Tiludronate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000941	0.0081	CcSEcCtD
Tiludronate—Myalgia—Triamcinolone—multiple sclerosis	0.000936	0.00807	CcSEcCtD
Tiludronate—Myalgia—Methylprednisolone—multiple sclerosis	0.000934	0.00805	CcSEcCtD
Tiludronate—Arthralgia—Methylprednisolone—multiple sclerosis	0.000934	0.00805	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00093	0.00126	CbGpPWpGaD
Tiludronate—Headache—Azathioprine—multiple sclerosis	0.000922	0.00794	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000912	0.00123	CbGpPWpGaD
Tiludronate—Vertigo—Dexamethasone—multiple sclerosis	0.000897	0.00772	CcSEcCtD
Tiludronate—Vertigo—Betamethasone—multiple sclerosis	0.000897	0.00772	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD28—multiple sclerosis	0.000882	0.00119	CbGpPWpGaD
Tiludronate—Nausea—Azathioprine—multiple sclerosis	0.000874	0.00753	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCR1—multiple sclerosis	0.000869	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000869	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL13—multiple sclerosis	0.000869	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR1—multiple sclerosis	0.000869	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CCR2—multiple sclerosis	0.000866	0.00117	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTPRC—multiple sclerosis	0.000866	0.00117	CbGpPWpGaD
Tiludronate—Asthenia—Mitoxantrone—multiple sclerosis	0.000854	0.00735	CcSEcCtD
Tiludronate—Myalgia—Dexamethasone—multiple sclerosis	0.00085	0.00732	CcSEcCtD
Tiludronate—Myalgia—Betamethasone—multiple sclerosis	0.00085	0.00732	CcSEcCtD
Tiludronate—PTPN1—Immune System—HLA-DPB1—multiple sclerosis	0.000837	0.00113	CbGpPWpGaD
Tiludronate—Pain—Prednisolone—multiple sclerosis	0.000835	0.00719	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	0.00083	0.00112	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000818	0.00704	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000816	0.00703	CcSEcCtD
Tiludronate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000814	0.00701	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CD28—multiple sclerosis	0.000814	0.0011	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD40—multiple sclerosis	0.000805	0.00109	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ITGA4—multiple sclerosis	0.000805	0.00109	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNB1—multiple sclerosis	0.000799	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTLA4—multiple sclerosis	0.000793	0.00107	CbGpPWpGaD
Tiludronate—Dyspepsia—Triamcinolone—multiple sclerosis	0.00079	0.00681	CcSEcCtD
Tiludronate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000788	0.00679	CcSEcCtD
Tiludronate—Vertigo—Prednisone—multiple sclerosis	0.000781	0.00673	CcSEcCtD
Tiludronate—Pain—Triamcinolone—multiple sclerosis	0.000768	0.00661	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—ALB—multiple sclerosis	0.000758	0.00103	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	0.000755	0.00102	CbGpPWpGaD
Tiludronate—Headache—Mitoxantrone—multiple sclerosis	0.000745	0.00642	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000742	0.00639	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000742	0.00639	CcSEcCtD
Tiludronate—Arthralgia—Prednisone—multiple sclerosis	0.00074	0.00637	CcSEcCtD
Tiludronate—Myalgia—Prednisone—multiple sclerosis	0.00074	0.00637	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000732	0.00631	CcSEcCtD
Tiludronate—Dyspepsia—Betamethasone—multiple sclerosis	0.000717	0.00618	CcSEcCtD
Tiludronate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000717	0.00618	CcSEcCtD
Tiludronate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000708	0.0061	CcSEcCtD
Tiludronate—Nausea—Mitoxantrone—multiple sclerosis	0.000707	0.00609	CcSEcCtD
Tiludronate—Back pain—Methotrexate—multiple sclerosis	0.000703	0.00605	CcSEcCtD
Tiludronate—PTPN1—Immune System—VCAM1—multiple sclerosis	0.0007	0.000948	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-DQA1—multiple sclerosis	0.000698	0.000945	CbGpPWpGaD
Tiludronate—Pain—Dexamethasone—multiple sclerosis	0.000697	0.006	CcSEcCtD
Tiludronate—Pain—Betamethasone—multiple sclerosis	0.000697	0.006	CcSEcCtD
Tiludronate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000666	0.00574	CcSEcCtD
Tiludronate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000666	0.00574	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000656	0.000888	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-DQB1—multiple sclerosis	0.000653	0.000884	CbGpPWpGaD
Tiludronate—Vertigo—Methotrexate—multiple sclerosis	0.000653	0.00562	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000646	0.00557	CcSEcCtD
Tiludronate—Dizziness—Prednisolone—multiple sclerosis	0.000646	0.00556	CcSEcCtD
Tiludronate—Asthenia—Triamcinolone—multiple sclerosis	0.000644	0.00555	CcSEcCtD
Tiludronate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000644	0.00555	CcSEcCtD
Tiludronate—Abdominal pain—Betamethasone—multiple sclerosis	0.000644	0.00555	CcSEcCtD
Tiludronate—Asthenia—Methylprednisolone—multiple sclerosis	0.000643	0.00554	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD86—multiple sclerosis	0.000629	0.000851	CbGpPWpGaD
Tiludronate—Dyspepsia—Prednisone—multiple sclerosis	0.000624	0.00538	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCL3—multiple sclerosis	0.000619	0.000838	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL3—multiple sclerosis	0.000619	0.000838	CbGpPWpGaD
Tiludronate—Arthralgia—Methotrexate—multiple sclerosis	0.000618	0.00533	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—multiple sclerosis	0.000618	0.00533	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD40LG—multiple sclerosis	0.000617	0.000835	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IL2—multiple sclerosis	0.000615	0.000832	CbGpPWpGaD
Tiludronate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000613	0.00528	CcSEcCtD
Tiludronate—Headache—Prednisolone—multiple sclerosis	0.000612	0.00527	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD8A—multiple sclerosis	0.00061	0.000826	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000596	0.000806	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTGER4—multiple sclerosis	0.000596	0.000806	CbGpPWpGaD
Tiludronate—Dizziness—Triamcinolone—multiple sclerosis	0.000594	0.00511	CcSEcCtD
Tiludronate—Dizziness—Methylprednisolone—multiple sclerosis	0.000592	0.0051	CcSEcCtD
Tiludronate—PTPN1—Immune System—HLA-B—multiple sclerosis	0.000587	0.000794	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PGR—multiple sclerosis	0.000587	0.000794	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PGR—multiple sclerosis	0.000587	0.000794	CbGpPWpGaD
Tiludronate—Asthenia—Dexamethasone—multiple sclerosis	0.000584	0.00503	CcSEcCtD
Tiludronate—Asthenia—Betamethasone—multiple sclerosis	0.000584	0.00503	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CD86—multiple sclerosis	0.000581	0.000786	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—multiple sclerosis	0.00058	0.000785	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00058	0.005	CcSEcCtD
Tiludronate—Nausea—Prednisolone—multiple sclerosis	0.00058	0.00499	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000575	0.000779	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCR3—multiple sclerosis	0.000575	0.000779	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CD28—multiple sclerosis	0.00057	0.000771	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CD28—multiple sclerosis	0.00057	0.000771	CbGpPWpGaD
Tiludronate—Headache—Triamcinolone—multiple sclerosis	0.000562	0.00484	CcSEcCtD
Tiludronate—Headache—Methylprednisolone—multiple sclerosis	0.000561	0.00483	CcSEcCtD
Tiludronate—Abdominal pain—Prednisone—multiple sclerosis	0.000561	0.00483	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCR2—multiple sclerosis	0.00056	0.000758	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR2—multiple sclerosis	0.00056	0.000758	CbGpPWpGaD
Tiludronate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000557	0.0048	CcSEcCtD
Tiludronate—Diarrhoea—Betamethasone—multiple sclerosis	0.000557	0.0048	CcSEcCtD
Tiludronate—PTPN1—Immune System—IL2RA—multiple sclerosis	0.00055	0.000744	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-A—multiple sclerosis	0.000544	0.000736	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00054	0.00465	CcSEcCtD
Tiludronate—Dizziness—Betamethasone—multiple sclerosis	0.000539	0.00464	CcSEcCtD
Tiludronate—Dizziness—Dexamethasone—multiple sclerosis	0.000539	0.00464	CcSEcCtD
Tiludronate—Nausea—Triamcinolone—multiple sclerosis	0.000533	0.00459	CcSEcCtD
Tiludronate—Nausea—Methylprednisolone—multiple sclerosis	0.000532	0.00458	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—multiple sclerosis	0.000522	0.0045	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CNR1—multiple sclerosis	0.000517	0.000699	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CNR1—multiple sclerosis	0.000517	0.000699	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CCR5—multiple sclerosis	0.000515	0.000697	CbGpPWpGaD
Tiludronate—Headache—Dexamethasone—multiple sclerosis	0.00051	0.0044	CcSEcCtD
Tiludronate—Headache—Betamethasone—multiple sclerosis	0.00051	0.0044	CcSEcCtD
Tiludronate—Asthenia—Prednisone—multiple sclerosis	0.000509	0.00438	CcSEcCtD
Tiludronate—Pain—Methotrexate—multiple sclerosis	0.000507	0.00437	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HLA-A—multiple sclerosis	0.000502	0.000679	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TLR4—multiple sclerosis	0.000497	0.000673	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-DRB1—multiple sclerosis	0.000497	0.000672	CbGpPWpGaD
Tiludronate—Diarrhoea—Prednisone—multiple sclerosis	0.000485	0.00418	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000485	0.00418	CcSEcCtD
Tiludronate—Nausea—Betamethasone—multiple sclerosis	0.000484	0.00417	CcSEcCtD
Tiludronate—Nausea—Dexamethasone—multiple sclerosis	0.000484	0.00417	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—TGFB1—multiple sclerosis	0.00048	0.000649	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ICAM1—multiple sclerosis	0.000477	0.000645	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK1—multiple sclerosis	0.00047	0.000636	CbGpPWpGaD
Tiludronate—Dizziness—Prednisone—multiple sclerosis	0.000469	0.00404	CcSEcCtD
Tiludronate—Abdominal pain—Methotrexate—multiple sclerosis	0.000469	0.00404	CcSEcCtD
Tiludronate—ATP6V1A—Disease—APOE—multiple sclerosis	0.000469	0.000634	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000465	0.000629	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL10—multiple sclerosis	0.000465	0.000629	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD80—multiple sclerosis	0.000459	0.000621	CbGpPWpGaD
Tiludronate—Headache—Prednisone—multiple sclerosis	0.000444	0.00383	CcSEcCtD
Tiludronate—Asthenia—Methotrexate—multiple sclerosis	0.000425	0.00366	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CD80—multiple sclerosis	0.000424	0.000573	CbGpPWpGaD
Tiludronate—Nausea—Prednisone—multiple sclerosis	0.000421	0.00363	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CD86—multiple sclerosis	0.000407	0.00055	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CD86—multiple sclerosis	0.000407	0.00055	CbGpPWpGaD
Tiludronate—Diarrhoea—Methotrexate—multiple sclerosis	0.000406	0.00349	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCL5—multiple sclerosis	0.0004	0.000542	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL5—multiple sclerosis	0.0004	0.000542	CbGpPWpGaD
Tiludronate—Dizziness—Methotrexate—multiple sclerosis	0.000392	0.00338	CcSEcCtD
Tiludronate—PTPN1—Immune System—TYK2—multiple sclerosis	0.000387	0.000524	CbGpPWpGaD
Tiludronate—Headache—Methotrexate—multiple sclerosis	0.000371	0.0032	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—SPP1—multiple sclerosis	0.000371	0.000502	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SPP1—multiple sclerosis	0.000371	0.000502	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNG—multiple sclerosis	0.000363	0.000491	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCR5—multiple sclerosis	0.000361	0.000488	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR5—multiple sclerosis	0.000361	0.000488	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TYK2—multiple sclerosis	0.000358	0.000484	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000355	0.000481	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2RA—multiple sclerosis	0.000355	0.000481	CbGpPWpGaD
Tiludronate—Nausea—Methotrexate—multiple sclerosis	0.000352	0.00303	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD4—multiple sclerosis	0.00035	0.000474	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—multiple sclerosis	0.000328	0.000444	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—multiple sclerosis	0.000328	0.000444	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—multiple sclerosis	0.000324	0.000438	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD4—multiple sclerosis	0.000323	0.000438	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—multiple sclerosis	0.000322	0.000436	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CD80—multiple sclerosis	0.000297	0.000402	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CD80—multiple sclerosis	0.000297	0.000402	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—POMC—multiple sclerosis	0.000282	0.000382	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—POMC—multiple sclerosis	0.000282	0.000382	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL2—multiple sclerosis	0.000276	0.000373	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL2—multiple sclerosis	0.000276	0.000373	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—multiple sclerosis	0.000271	0.000367	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TYK2—multiple sclerosis	0.00025	0.000339	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TYK2—multiple sclerosis	0.00025	0.000339	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—multiple sclerosis	0.00025	0.000339	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK1—multiple sclerosis	0.000247	0.000334	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—multiple sclerosis	0.000233	0.000315	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—multiple sclerosis	0.000232	0.000314	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK1—multiple sclerosis	0.000228	0.000308	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—multiple sclerosis	0.000208	0.000282	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—multiple sclerosis	0.000208	0.000282	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—multiple sclerosis	0.000197	0.000267	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—multiple sclerosis	0.000197	0.000267	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—multiple sclerosis	0.000189	0.000256	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—multiple sclerosis	0.000175	0.000237	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—multiple sclerosis	0.000175	0.000237	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—multiple sclerosis	0.000175	0.000237	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—multiple sclerosis	0.000163	0.000221	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—multiple sclerosis	0.000163	0.000221	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—multiple sclerosis	0.000163	0.00022	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—multiple sclerosis	0.000163	0.00022	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK1—multiple sclerosis	0.000159	0.000216	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK1—multiple sclerosis	0.000159	0.000216	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—multiple sclerosis	0.000122	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—multiple sclerosis	0.000122	0.000166	CbGpPWpGaD
